Analyst Ratings For NITE – Nightstar Therapeutics (NASDAQ:NITE)
Today, Wedbush reiterated its Outperform rating on NITE – Nightstar Therapeutics (NASDAQ:NITE) with a price target of $31.00.
Some recent analyst ratings include
- 4/5/2018-Wedbush Reiterated Rating of Outperform.
- 4/5/2018-Mizuho Reiterated Rating of Buy.
- 1/3/2018-Chardan Capital initiated coverage with a Buy rating.
- 10/23/2017-Leerink Swann initiated coverage with a Outperform rating.
- 10/23/2017-Jefferies Group initiated coverage with a Buy rating.
- 10/23/2017-BMO Capital Markets initiated coverage with a Outperform rating.
Recent Trading Activity for NITE – Nightstar Therapeutics (NASDAQ:NITE)
Shares of NITE – Nightstar Therapeutics closed the previous trading session at 12.33 +0.00 0.00% with 12.510000228881836 shares trading hands.